The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Life science and energy tech company AnteoTech (ADO) appoints David Radford as its new Managing Director and CEO
  • The appointment follows a five-month search after CEO Derek Thomson announced his resignation in mid-March
  • Mr Radford is an internationally experienced CEO and Company Director and was recently the CEO of Australian medical device company AllVascular
  • He will begin his role on October 4 when Mr Thomson finishes his six-month notice period in accordance with his contract
  • ADO shares are up 4.11 per cent on the market and trading at 7.6 cents at 1:13 pm AEST

Life science and energy tech company AnteoTech (ADO) has appointed David Radford as its new Managing Director and CEO.

The appointment follows a five-month search after CEO Derek Thomson announced his resignation in mid-March.

Mr Radford is an internationally experienced CEO and Company Director and has experience in coordinating international teams, executing business turnarounds,
product development and product launches, and operational initiatives to drive material growth in revenue and profits.

Recently, he was the CEO of Australian medical device company AllVascular, which
develops and sells patented drug delivery technology.

Mr Radford will begin his new roles on October 4 when Mr Thomson finishes his six-month notice period in accordance with his contract.

“I thank the AnteoTech board for the opportunity to join the company as CEO, at what marks a particularly exciting time in the company’s evolution,” Mr Radford said.

“Through my engagement with the board, I am confident the business has established a strong foundation to deliver on its core operational objectives in the months and years ahead.”

Chairman Ewen Crouch has thanked Mr Thomson for his contribution to the company and is looking forward to working with Mr Radford.

“The board considered that Mr Radford’s strategic acumen, industry knowledge and high-level C-suite experience made him the standout candidate from a competitive field of applicants following an extensive global search process,” he said.

ADO shares were up 4.11 per cent on the market and trading at 7.6 cents at 1:13 pm AEST.

ADO by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.